| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2021/10/26 | 19 : 59 | Business Wire | Crestwood to Acquire Oasis Midstream Partners in $1.8 Billion Transaction | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/25 | 21 : 00 | PR Newswire (US) | Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc. | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/24 | 21 : 00 | PR Newswire (US) | Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/23 | 21 : 00 | PR Newswire (US) | Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstand... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/22 | 21 : 00 | PR Newswire (US) | Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisitio... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/18 | 05 : 28 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/13 | 06 : 30 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/13 | 06 : 17 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/13 | 06 : 17 | Edgar (US Regulatory) | Post-effective Amendment (investment Company, Rule 485(a)) (485apos) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/09 | 23 : 43 | Zacks | Valeant: The Sole Suitor for Obagi - Analyst Blog | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/08 | 22 : 20 | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/08 | 21 : 22 | Dow Jones News | Merz Pharma Withdraws Offer for Obagi Medical After Valeant's Sweetened Bid | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/08 | 20 : 32 | PR Newswire (US) | Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/06 | 05 : 56 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/06 | 05 : 49 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/05 | 06 : 20 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/05 | 02 : 50 | Zacks | Valeant Ups Offer for Obagi - Analyst Blog | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/04 | 19 : 02 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/04 | 06 : 19 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/04 | 03 : 51 | GlobeNewswire Inc. | CORRECTING and REPLACING -- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/04 | 02 : 47 | GlobeNewswire Inc. | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Obagi Medic | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/04 | 00 : 26 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/03 | 22 : 13 | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/03 | 22 : 02 | Dow Jones News | Valeant Boosts Price for Obagi to $420 Million, Besting Merz Offer | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/03 | 21 : 00 | PR Newswire (US) | Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/03 | 21 : 00 | Business Wire | Obagi Medical Products, Inc. and Valeant Pharmaceuticals, Inc. Agree on an Increased Offer Price of $24.00 per Share in Cash | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/03 | 06 : 18 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/03 | 05 : 22 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/03 | 02 : 42 | Dow Jones News | UPDATE: Merz Pharma Offers to Buy Obagi, Looks to Top Valeant Deal | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 2013/04/03 | 01 : 30 | Business Wire | Board of Directors of Obagi Medical Products, Inc. Receives Unsolicited Acquisition Proposal from Merz Pharma | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |